Compile Data Set for Download or QSAR
Report error Found 45 Enz. Inhib. hit(s) with all data for entry = 50009230
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526389(CHEMBL4450081)
Affinity DataIC50: 10nMAssay Description:Inhibition of full length recombinant human FASN using acetyl-CoA/malonyl-CoA as substrate preincubated for 60 mins followed by substrate addition an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526400(CHEMBL4553437)
Affinity DataIC50: 11nMAssay Description:Inhibition of FASN in human BT474 cells preincubated for 1 hr followed by [14C]-acetate addition and measured after 4 hrs by scintillation counting a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526390(CHEMBL4462401)
Affinity DataIC50: 11nMAssay Description:Inhibition of FASN in human BT474 cells preincubated for 1 hr followed by [14C]-acetate addition and measured after 4 hrs by scintillation counting a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526389(CHEMBL4450081)
Affinity DataIC50: 12nMAssay Description:Inhibition of FASN in human BT474 cells preincubated for 1 hr followed by [14C]-acetate addition and measured after 4 hrs by scintillation counting a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526397(CHEMBL4440024)
Affinity DataIC50: 12nMAssay Description:Inhibition of full length recombinant human FASN using acetyl-CoA/malonyl-CoA as substrate preincubated for 60 mins followed by substrate addition an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526400(CHEMBL4553437)
Affinity DataIC50: 13nMAssay Description:Inhibition of full length recombinant human FASN using acetyl-CoA/malonyl-CoA as substrate preincubated for 60 mins followed by substrate addition an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526391(CHEMBL4529391)
Affinity DataIC50: 16nMAssay Description:Inhibition of full length recombinant human FASN using acetyl-CoA/malonyl-CoA as substrate preincubated for 60 mins followed by substrate addition an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526391(CHEMBL4529391)
Affinity DataIC50: 18nMAssay Description:Inhibition of FASN in human BT474 cells preincubated for 1 hr followed by [14C]-acetate addition and measured after 4 hrs by scintillation counting a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526397(CHEMBL4440024)
Affinity DataIC50: 19nMAssay Description:Inhibition of FASN in human BT474 cells preincubated for 1 hr followed by [14C]-acetate addition and measured after 4 hrs by scintillation counting a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526383(CHEMBL4575847)
Affinity DataIC50: 26nMAssay Description:Inhibition of full length recombinant human FASN using acetyl-CoA/malonyl-CoA as substrate preincubated for 60 mins followed by substrate addition an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526388(CHEMBL4518496)
Affinity DataIC50: 32nMAssay Description:Inhibition of full length recombinant human FASN using acetyl-CoA/malonyl-CoA as substrate preincubated for 60 mins followed by substrate addition an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526390(CHEMBL4462401)
Affinity DataIC50: 32nMAssay Description:Inhibition of full length recombinant human FASN using acetyl-CoA/malonyl-CoA as substrate preincubated for 60 mins followed by substrate addition an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526382(CHEMBL4466578)
Affinity DataIC50: 33nMAssay Description:Inhibition of full length recombinant human FASN using acetyl-CoA/malonyl-CoA as substrate preincubated for 60 mins followed by substrate addition an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526387(CHEMBL4449818)
Affinity DataIC50: 54nMAssay Description:Inhibition of full length recombinant human FASN using acetyl-CoA/malonyl-CoA as substrate preincubated for 60 mins followed by substrate addition an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526399(CHEMBL4570684)
Affinity DataIC50: 57nMAssay Description:Inhibition of full length recombinant human FASN using acetyl-CoA/malonyl-CoA as substrate preincubated for 60 mins followed by substrate addition an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526401(CHEMBL4445590)
Affinity DataIC50: 61nMAssay Description:Inhibition of FASN in human BT474 cells preincubated for 1 hr followed by [14C]-acetate addition and measured after 4 hrs by scintillation counting a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526399(CHEMBL4570684)
Affinity DataIC50: 67nMAssay Description:Inhibition of FASN in human BT474 cells preincubated for 1 hr followed by [14C]-acetate addition and measured after 4 hrs by scintillation counting a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526386(CHEMBL4575998)
Affinity DataIC50: 69nMAssay Description:Inhibition of full length recombinant human FASN using acetyl-CoA/malonyl-CoA as substrate preincubated for 60 mins followed by substrate addition an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526382(CHEMBL4466578)
Affinity DataIC50: 70nMAssay Description:Inhibition of FASN in human BT474 cells preincubated for 1 hr followed by [14C]-acetate addition and measured after 4 hrs by scintillation counting a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526381(CHEMBL4565279)
Affinity DataIC50: 90nMAssay Description:Inhibition of FASN in human BT474 cells preincubated for 1 hr followed by [14C]-acetate addition and measured after 4 hrs by scintillation counting a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526385(CHEMBL4440104)
Affinity DataIC50: 97nMAssay Description:Inhibition of full length recombinant human FASN using acetyl-CoA/malonyl-CoA as substrate preincubated for 60 mins followed by substrate addition an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526388(CHEMBL4518496)
Affinity DataIC50: 101nMAssay Description:Inhibition of FASN in human BT474 cells preincubated for 1 hr followed by [14C]-acetate addition and measured after 4 hrs by scintillation counting a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526387(CHEMBL4449818)
Affinity DataIC50: 101nMAssay Description:Inhibition of FASN in human BT474 cells preincubated for 1 hr followed by [14C]-acetate addition and measured after 4 hrs by scintillation counting a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526385(CHEMBL4440104)
Affinity DataIC50: 104nMAssay Description:Inhibition of FASN in human BT474 cells preincubated for 1 hr followed by [14C]-acetate addition and measured after 4 hrs by scintillation counting a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526403(CHEMBL4457855)
Affinity DataIC50: 110nMAssay Description:Inhibition of full length recombinant human FASN using acetyl-CoA/malonyl-CoA as substrate preincubated for 60 mins followed by substrate addition an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526398(CHEMBL4454062)
Affinity DataIC50: 110nMAssay Description:Inhibition of full length recombinant human FASN using acetyl-CoA/malonyl-CoA as substrate preincubated for 60 mins followed by substrate addition an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526386(CHEMBL4575998)
Affinity DataIC50: 136nMAssay Description:Inhibition of FASN in human BT474 cells preincubated for 1 hr followed by [14C]-acetate addition and measured after 4 hrs by scintillation counting a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526404(CHEMBL4548362)
Affinity DataIC50: 142nMAssay Description:Inhibition of full length recombinant human FASN using acetyl-CoA/malonyl-CoA as substrate preincubated for 60 mins followed by substrate addition an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526398(CHEMBL4454062)
Affinity DataIC50: 158nMAssay Description:Inhibition of FASN in human BT474 cells preincubated for 1 hr followed by [14C]-acetate addition and measured after 4 hrs by scintillation counting a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526401(CHEMBL4445590)
Affinity DataIC50: 192nMAssay Description:Inhibition of full length recombinant human FASN using acetyl-CoA/malonyl-CoA as substrate preincubated for 60 mins followed by substrate addition an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526381(CHEMBL4565279)
Affinity DataIC50: 213nMAssay Description:Inhibition of full length recombinant human FASN using acetyl-CoA/malonyl-CoA as substrate preincubated for 60 mins followed by substrate addition an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526404(CHEMBL4548362)
Affinity DataIC50: 257nMAssay Description:Inhibition of FASN in human BT474 cells preincubated for 1 hr followed by [14C]-acetate addition and measured after 4 hrs by scintillation counting a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526393(CHEMBL4439223)
Affinity DataIC50: 310nMAssay Description:Inhibition of full length recombinant human FASN using acetyl-CoA/malonyl-CoA as substrate preincubated for 60 mins followed by substrate addition an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526403(CHEMBL4457855)
Affinity DataIC50: 336nMAssay Description:Inhibition of FASN in human BT474 cells preincubated for 1 hr followed by [14C]-acetate addition and measured after 4 hrs by scintillation counting a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526379(CHEMBL4442092)
Affinity DataIC50: 350nMAssay Description:Inhibition of full length recombinant human FASN using acetyl-CoA/malonyl-CoA as substrate preincubated for 60 mins followed by substrate addition an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526405(CHEMBL4439986)
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of full length recombinant human FASN using acetyl-CoA/malonyl-CoA as substrate preincubated for 60 mins followed by substrate addition an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526384(CHEMBL4581195)
Affinity DataIC50: 1.14E+3nMAssay Description:Inhibition of full length recombinant human FASN using acetyl-CoA/malonyl-CoA as substrate preincubated for 60 mins followed by substrate addition an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526395(CHEMBL4444430)
Affinity DataIC50: 1.80E+3nMAssay Description:Inhibition of full length recombinant human FASN using acetyl-CoA/malonyl-CoA as substrate preincubated for 60 mins followed by substrate addition an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526392(CHEMBL4455553)
Affinity DataIC50: 3.10E+3nMAssay Description:Inhibition of full length recombinant human FASN using acetyl-CoA/malonyl-CoA as substrate preincubated for 60 mins followed by substrate addition an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526393(CHEMBL4439223)
Affinity DataIC50: 4.96E+3nMAssay Description:Inhibition of FASN in human BT474 cells preincubated for 1 hr followed by [14C]-acetate addition and measured after 4 hrs by scintillation counting a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526380(CHEMBL4587129)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of full length recombinant human FASN using acetyl-CoA/malonyl-CoA as substrate preincubated for 60 mins followed by substrate addition an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526394(CHEMBL4471793)
Affinity DataIC50: 3.50E+4nMAssay Description:Inhibition of full length recombinant human FASN using acetyl-CoA/malonyl-CoA as substrate preincubated for 60 mins followed by substrate addition an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526402(CHEMBL4458935)
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of full length recombinant human FASN using acetyl-CoA/malonyl-CoA as substrate preincubated for 60 mins followed by substrate addition an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526396(CHEMBL4447234)
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of full length recombinant human FASN using acetyl-CoA/malonyl-CoA as substrate preincubated for 60 mins followed by substrate addition an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFatty acid synthase(Human)
Forma Therapeutics

Curated by ChEMBL
LigandPNGBDBM50526380(CHEMBL4587129)
Affinity DataIC50: 1.25E+5nMAssay Description:Inhibition of FASN in human BT474 cells preincubated for 1 hr followed by [14C]-acetate addition and measured after 4 hrs by scintillation counting a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed